Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome

Neurotoxicity syndromes

Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome Effect of Antibiotic Choice On ReNal Outcomes (ACORN) Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations EEG Encephalopathy Patterns in Immune Effectors Cells-associated Neurotoxicity Syndrome (ICANS)Lay Language Neurotoxicity Due to Chimeric Antigen Receptor-modified (CAR) T Cell Therapy Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer Peri-Anesthetic Imaging of Cognitive Dysfunction Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer Acute Pain Caused by Paclitaxel in Patients With Cancer Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer A Pilot Study to Evaluate Impact on Neurological Side Effects (Cognition, Memory, and Tremor) in Elderly (Age>65) Patients Cassava Intervention Project Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate Advanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer Nerve Function in Older Diabetic Patients Who Are Undergoing Chemotherapy for Metastatic Solid Tumors Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201 Scopolamine Treatment for Patients With Organophosphate Poisoning Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer Clinical Trial of Electroacupuncture Stimulation on Prevention and Treatment of Oxaliplatin Neurotoxicity Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy Envarsus Neurotoxicity Burden in Liver Transplant Patients To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Anakinra In Car-T Cell Mediated Neurotoxicity Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients Neurotoxicity Evaluation of bétalactamines in Intensive Care Unit and Identification of the Risk Factors A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity Enzymatic Evaluation of General Anesthetic Induced Neurotoxicity in Patients With Aneurysmal Subarachnoid Hemorrhage